Search Page

1

Cite

Share

TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.

Nguyen KQ, Tsou WI, Kotenko S, Birge RB. Nguyen KQ, et al. Autoimmunity. 2013 Aug;46(5):294-7. doi: 10.3109/08916934.2013.794515. Epub 2013 May 10. Autoimmunity. 2013. PMID: 23662598 Review.

Cite

Share

2

Cite

Share

Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment.

Kumar S, Calianese D, Birge RB. Kumar S, et al. Immunol Rev. 2017 Nov;280(1):149-164. doi: 10.1111/imr.12587. Immunol Rev. 2017. PMID: 29027226 Free PMC article. Review.

Cite

Share

3

Cite

Share

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.

Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, Barcinski M, Brekken RA, Huang X, Hutchins JT, Freimark B, Empig C, Mercer J, Schroit AJ, Schett G, Herrmann M. Birge RB, et al. Cell Death Differ. 2016 Jun;23(6):962-78. doi: 10.1038/cdd.2016.11. Epub 2016 Feb 26. Cell Death Differ. 2016. PMID: 26915293 Free PMC article. Review.

Cite

Share

4

Cite

Share

Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer.

Davra V, Saleh T, Geng K, Kimani S, Mehta D, Kasikara C, Smith B, Colangelo NW, Ciccarelli B, Li H, Azzam EI, Kalodimos CG, Birge RB, Kumar S. Davra V, et al. Mol Cancer Res. 2020 Aug;18(8):1189-1201. doi: 10.1158/1541-7786.MCR-19-1144. Epub 2020 Apr 22. Mol Cancer Res. 2020. PMID: 32321766 Free PMC article.

Cite

Share

5

Cite

Share

Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.

Saleh T, Jankowski W, Sriram G, Rossi P, Shah S, Lee KB, Cruz LA, Rodriguez AJ, Birge RB, Kalodimos CG. Saleh T, et al. Nat Chem Biol. 2016 Feb;12(2):117-23. doi: 10.1038/nchembio.1981. Epub 2015 Dec 14. Nat Chem Biol. 2016. PMID: 26656091 Free PMC article.

Cite

Share

6

Cite

Share

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.

Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, Sriram G, Devoe C, Nguyen KN, Antes A, Krantz A, Rymarczyk G, Wilczynski A, Empig C, Freimark B, Gray M, Schlunegger K, Hutchins J, Kotenko SV, Birge RB. Kasikara C, et al. Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9. Mol Cancer Res. 2017. PMID: 28184013 Free PMC article.

Cite

Share

7

Cite

Share

Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.

Sriram G, Jankowski W, Kasikara C, Reichman C, Saleh T, Nguyen KQ, Li J, Hornbeck P, Machida K, Liu T, Li H, Kalodimos CG, Birge RB. Sriram G, et al. Oncogene. 2015 Aug 6;34(32):4260-9. doi: 10.1038/onc.2014.361. Epub 2014 Nov 10. Oncogene. 2015. PMID: 25381819 Free PMC article.

Cite

Share

8

Cite

Share

MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity.

Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I. Cai B, et al. Sci Signal. 2018 Sep 25;11(549):eaar3721. doi: 10.1126/scisignal.aar3721. Sci Signal. 2018. PMID: 30254055 Free PMC article.

Cite

Share

9

Cite

Share

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.

Kimani SG, Kumar S, Davra V, Chang YJ, Kasikara C, Geng K, Tsou WI, Wang S, Hoque M, Boháč A, Lewis-Antes A, De Lorenzo MS, Kotenko SV, Birge RB. Kimani SG, et al. Cell Commun Signal. 2016 Sep 6;14(1):19. doi: 10.1186/s12964-016-0142-1. Cell Commun Signal. 2016. PMID: 27595981 Free PMC article.

Cite

Share

10

Cite

Share

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer.

Knott ME, Minatta JN, Roulet L, Gueglio G, Pasik L, Ranuncolo SM, Nuñez M, Puricelli L, De Lorenzo MS. Knott ME, et al. J Mol Biomark Diagn. 2016 Jun;1(Suppl 2):015. doi: 10.4172/2155-9929.S2-015. Epub 2016 May 20. J Mol Biomark Diagn. 2016. PMID: 27358750 Free PMC article.

Cite

Share